The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro (British Journal of Cancer (2008) 98, (1085-1093) DOI: 10.1038/sj.bjc.6604281))

O'Brien, PM; Davies, MJ; Scurry, JP; Smith, AN; Barton, CA; Henderson, MJ; Saunders, DN; Gloss, BS; Patterson, KI; Clancy, JL; Heinzelmann-Schwarz, VA; Murali, R; Scolyer, RA; Zeng, Y; Williams, ED; Scurr, L; DeFazio, A; Quinn, DI; Watts, CKW; Hacker, NF; Henshall, SM; Sutherland, RL

The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro (British Journal of Cancer (2008) 98, (1085-1093) DOI: 10.1038/sj.bjc.6604281))

journal contribution

posted on 2025-07-23, 02:57 authored by PM O'Brien, MJ Davies, JP Scurry, AN Smith, CA Barton, MJ Henderson, DN Saunders, BS Gloss, KI Patterson, JL Clancy, VA Heinzelmann-Schwarz, R Murali, RA Scolyer, Y Zeng, ED Williams, L Scurr, A DeFazio, DI Quinn, CKW Watts, NF Hacker, SM Henshall, RL Sutherland

The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro (British Journal of Cancer (2008) 98, (1085-1093) DOI: 10.1038/sj.bjc.6604281))

History

Related Materials

1.
DOI - Is version of https://doi.org/10.1038/sj.bjc.6604419

Location

London, Eng.

Open access

Yes

Language

eng

Journal

British Journal of Cancer

Volume

98

Pagination

1880-1880

ISSN

0007-0920

eISSN

1532-1827

Issue

11

Publisher

Springer Nature

The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro (British Journal of Cancer (2008) 98, (1085-1093) DOI: 10.1038/sj.bjc.6604281))

History

Related Materials

Location

Open access

Language

Journal

Volume

Pagination

ISSN

eISSN

Issue

Publisher

Usage metrics

Categories

Keywords

Licence

Exports